<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We report a case of <z:e sem="disease" ids="C0002986" disease_type="Disease or Syndrome" abbrv="">Anderson-Fabry disease</z:e> in a young man presenting with <z:mp ids='MP_0001625'>cardiac hypertrophy</z:mp> and asymptomatic non-sustained <z:hpo ids='HP_0004756'>ventricular tachycardia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>The patient was referred for evaluation of implantable cardioverter/defibrillator therapy </plain></SENT>
<SENT sid="2" pm="."><plain>Assessment of left ventricular ejection fraction is considered the gold standard for identifying patients at risk of <z:hpo ids='HP_0001645'>sudden cardiac death</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>However, this patient's left ventricular function was preserved </plain></SENT>
<SENT sid="4" pm="."><plain>Electrophysiological study did not reveal inducible <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> or <z:hpo ids='HP_0011675'>cardiac conduction abnormalities</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>Review of the literature indicates limited knowledge on the electrophysiology of Fabry <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> and highlights the need for optimized risk stratification strategies </plain></SENT>
</text></document>